Clinical Field definition

Clinical Field means the treatment of autoimmune diseases and transplant indications, limited to the following diseases: autoimmune hemolytic anemia, immune thrombocytopenic purpura, AIDS-associated myopathy, AIDS-associated neuropathy, Acute disseminated encephalomyelitis, Addison’s Disease, Alopecia Areata, Anaphylaxis Reactions, Ankylosing Spondylitis, Antibody-related Neuropathies, Antiphospholipid Syndrome, Autism, Autoimmune Atherosclerosis, Autoimmune Endometriosis, Autoimmune Eye Diseases, Autoimmune Gastritis, Autoimmune Hepatitis, Auto immune Interstitial Cystitis, Auto immune Lympho proliferative Syndrome, Autoimmune Myelopathy, Autoimmune Myocarditis, Autoimmune Neuropathies, Autoimmune Oophoritis, Autoimmune Orchitis, Autoimmune Thyroid Diseases, Autoimmune Urticaria, Autoimmune Uveitis, Autoimmune Vasculitis, Behcet’s Disease, ▇▇▇▇’▇ Palsy, Bullous Pemphigoid, CREST, Celiac Disease, Cerebellar degeneration (paraneoplastic), Chronic Fatigue Syndrome, Chronic Rhinosinusitis, Chronic inflammatory demyelinating polyneuropathy, Churg ▇▇▇▇▇▇▇ Syndrome, Connective Tissue Diseases, Type 1 Diabetes, Cutaneous Lupus, Dermatitis Herpetiformis, Dermatomyositis, Discoid Lupus Erythematosus, Drug-induced Lupus, Endocrine Orbitopathy, Glomerulonephritis, ▇▇▇▇▇▇▇▇▇▇▇ Syndrome, ▇▇▇▇▇▇▇▇▇▇▇’▇ Syndrome, ▇▇▇▇▇▇ Disease, Guillian-Barre Syndrome, ▇▇▇▇▇▇ ▇▇▇▇▇▇ variant of the Guillian Barre Syndrome, axonal Guillian Barre Syndrome, demyelinating Guillian Barre Syndrome, Hashimoto Thyroiditis, Herpes Gestationis, Human T-cell lymphomavirus-associated myelopathy, Huntington’s Disease, IgA Nephropathy, Inclusion body myositis, Interstitial Cystitis, ▇▇▇▇▇▇ syndrome, ▇▇▇▇▇▇▇ ▇▇▇▇▇ myasthenic syndrome, Limbic encephalitis, Lower motor neuron disease, Lyme Disease, MCTD, Microscopic Polyangiitis, ▇▇▇▇▇▇ ▇▇▇▇▇▇ Syndrome, Mixed Connective Tissue Disease, Mononeuritis multiplex (vasculitis), Myxedema, Meniere Disease, Neonatal LE, Neuropathies with dysproteinemias, Opsoclonus-myoclonus, PBC, POEMS syndrome, Paraneoplastic Autoimmune Syndromes, Pemphigus Foliaceus, Pernicious Anemia, Peyronie’s Disease, Plasmacytoma/myeloma neuropathy, Poly-Dermatomyositis, Polyarteritis Nodosa, Polyendocrine Deficiency Syndrome, Polyendocrine Deficiency Syndrome Type 1, Polyendocrine Deficiency Syndrome Type 2, Polyglandular Autoimmune Syndrome Type I, Polyglandular Autoimmune Syndrome Type II, Polyglandular Autoimmune Syndrome Type III, Polymyositis, Primary Biliary Cirrhosis, Primary Glomerulonephritis,...
View Source
Clinical Field means (i) in vivo administration of a Licensed Product for human therapeutic purposes, and (ii) ex vivo administration of a Licensed Product to cells or tissues to be implanted in a human patient. Both (i) and (ii) in the preceding sentence shall include clinical trials.
View Source
Clinical Field means the clinical diagnostic market.
View Source

Examples of Clinical Field in a sentence

  • Contractor’s work schedules and assignments will provide reasonable working conditions for ambulance, Field Supervisor and Clinical Field Specialist personnel.

  • Neither ambulance nor Field Supervisor or Clinical Field Specialist personnel shall be fatigued to an extent that their judgment or motor skills might be impaired.

  • Ambulance, Field Supervisor and Clinical Field Specialist personnel shall have sufficient rest periods to ensure that they remain alert and well rested during work periods.

  • For additional information, I will seek out and carefully review the policies and protocols for reporting child abuse outlined by the district in which I complete my Clinical Field Experience.

  • With respect to the development of Hearing Aid DSP Fitting Systems, Scientific Research Programs (including DSP Hearing Aid Basic Algorithms), Clinical Field Testing and Marketing Collateral, Danavox and ReSound may conduct such activities independently or, if Danavox and ReSound agree, jointly through AL2.

  • In consideration of the clinical development, marketing, regulatory and other manufacturing and development costs which have been incurred by Baxter prior to the execution of this Agreement, Accentia shall pay to Baxter, on a quarterly basis, a payment of two and one-half percent (2.5%) of Net Sales of Accentia Product used in treatments included under Clinical Field or Exclusive Clinical Field, calculated on a calendar quarter basis (each such payment, a “Net Sales Payment”).

  • I understand that I may be placed at a field site that may require significant travel time during my Clinical Field Experiences.

  • During the term of the Agreement, Baxter hereby grants Accentia the exclusive right to reference ▇▇▇▇▇▇’▇ approved application (i.e., NDA/ANDA) for cyclophosphamide with any Regulatory Authority (including without limitation the FDA), as well as any related documentation or materials to the extent required by such Regulatory Authority, in each case only to the extent necessary for the limited purpose of conducting clinical trials and making regulatory filings related to the Exclusive Clinical Field.

  • For the avoidance of doubt, this license shall be limited to the Field and shall not include the Clinical Field.

  • Accentia shall comply with all applicable law and regulations in its use and handling of the Product, and shall not use the Product in any unapproved or unlawful manner (other than in connection with clinical trial(s) for indications under the Clinical Field).

Related to Clinical Field

  • Licensed Field means all fields of use.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Licensed Product means any pharmaceutical product containing a Licensed Compound (alone or with other active ingredients), in all forms, presentations, formulations and dosage forms.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).